Features of myocardial infarction with ST segment elevation in patients with non-alcoholic liver steatosis and steatohepatitis

Clinical pharmacology and therapy Pub Date : 2023-11-04 DOI:10.32756/0869-5490-2023-4-51-57

V. A. Tretyakova, O. V. Ermilov, P. K. Alferov

引用次数: 0

Abstract

To evaluate the features of ST-segment elevation myocardial infarction (STEMI) in patients with two types of metabolic-associated fatty liver disease (MAFLD), that is, liver steatosis (LS) and steatohepatitis (SH).

查看原文本刊更多论文

非酒精性脂肪肝和脂肪性肝炎患者心肌梗死伴 ST 段抬高的特征

目的：评估两种代谢相关性脂肪肝（MAFLD）（即肝脂肪变性（LS）和脂肪性肝炎（SH））患者 ST 段抬高型心肌梗死（STEMI）的特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical pharmacology and therapy

自引率

0.00%

发文量